Hepatopulmonary Syndrome clinical trials at UCSF
1 research study open to eligible people
Hepatopulmonary Syndrome is a condition that affects the lungs and liver. UCSF is currently recruiting patients for a clinical trial called "Letrozole in Patients With Hepatopulmonary Syndrome". The trial will test the safety and benefits of letrozole compared to placebo for people with this condition.
Showing trials for
Letrozole in Patients With Hepatopulmonary Syndrome
open to eligible people ages 18-99
The purpose of this study is to assess the safety, tolerability and possible benefit of letrozole compared to placebo in patients with Hepatopulmonary Syndrome.
San Francisco, California and other locations
Our lead scientists for Hepatopulmonary Syndrome research studies include Yvonne Kelly, MD.